IBDEI0KH ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25924,1,4,0)
 ;;=4^Z59.4
 ;;^UTILITY(U,$J,358.3,25924,2)
 ;;=^5063133
 ;;^UTILITY(U,$J,358.3,25925,0)
 ;;=Z59.5^^69^1069^2
 ;;^UTILITY(U,$J,358.3,25925,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25925,1,3,0)
 ;;=3^Extreme Poverty
 ;;^UTILITY(U,$J,358.3,25925,1,4,0)
 ;;=4^Z59.5
 ;;^UTILITY(U,$J,358.3,25925,2)
 ;;=^5063134
 ;;^UTILITY(U,$J,358.3,25926,0)
 ;;=Z59.6^^69^1069^8
 ;;^UTILITY(U,$J,358.3,25926,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25926,1,3,0)
 ;;=3^Low Income
 ;;^UTILITY(U,$J,358.3,25926,1,4,0)
 ;;=4^Z59.6
 ;;^UTILITY(U,$J,358.3,25926,2)
 ;;=^5063135
 ;;^UTILITY(U,$J,358.3,25927,0)
 ;;=Z59.7^^69^1069^6
 ;;^UTILITY(U,$J,358.3,25927,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25927,1,3,0)
 ;;=3^Insufficient Social Insurance/Welfare Support
 ;;^UTILITY(U,$J,358.3,25927,1,4,0)
 ;;=4^Z59.7
 ;;^UTILITY(U,$J,358.3,25927,2)
 ;;=^5063136
 ;;^UTILITY(U,$J,358.3,25928,0)
 ;;=Z59.9^^69^1069^4
 ;;^UTILITY(U,$J,358.3,25928,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25928,1,3,0)
 ;;=3^Housing/Economic Problems,Unspec
 ;;^UTILITY(U,$J,358.3,25928,1,4,0)
 ;;=4^Z59.9
 ;;^UTILITY(U,$J,358.3,25928,2)
 ;;=^5063138
 ;;^UTILITY(U,$J,358.3,25929,0)
 ;;=G21.19^^69^1070^10
 ;;^UTILITY(U,$J,358.3,25929,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25929,1,3,0)
 ;;=3^Medication-Induced Parkinsonism,Other
 ;;^UTILITY(U,$J,358.3,25929,1,4,0)
 ;;=4^G21.19
 ;;^UTILITY(U,$J,358.3,25929,2)
 ;;=^5003773
 ;;^UTILITY(U,$J,358.3,25930,0)
 ;;=G21.11^^69^1070^13
 ;;^UTILITY(U,$J,358.3,25930,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25930,1,3,0)
 ;;=3^Neuroleptic-Induced Parkinsonism
 ;;^UTILITY(U,$J,358.3,25930,1,4,0)
 ;;=4^G21.11
 ;;^UTILITY(U,$J,358.3,25930,2)
 ;;=^5003772
 ;;^UTILITY(U,$J,358.3,25931,0)
 ;;=G24.01^^69^1070^15
 ;;^UTILITY(U,$J,358.3,25931,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25931,1,3,0)
 ;;=3^Tardive Dyskinesia
 ;;^UTILITY(U,$J,358.3,25931,1,4,0)
 ;;=4^G24.01
 ;;^UTILITY(U,$J,358.3,25931,2)
 ;;=^5003784
 ;;^UTILITY(U,$J,358.3,25932,0)
 ;;=G24.09^^69^1070^16
 ;;^UTILITY(U,$J,358.3,25932,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25932,1,3,0)
 ;;=3^Tardive Dystonia
 ;;^UTILITY(U,$J,358.3,25932,1,4,0)
 ;;=4^G24.09
 ;;^UTILITY(U,$J,358.3,25932,2)
 ;;=^5003786
 ;;^UTILITY(U,$J,358.3,25933,0)
 ;;=G25.1^^69^1070^11
 ;;^UTILITY(U,$J,358.3,25933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25933,1,3,0)
 ;;=3^Medication-Induced Postural Tremor
 ;;^UTILITY(U,$J,358.3,25933,1,4,0)
 ;;=4^G25.1
 ;;^UTILITY(U,$J,358.3,25933,2)
 ;;=^5003792
 ;;^UTILITY(U,$J,358.3,25934,0)
 ;;=G25.71^^69^1070^14
 ;;^UTILITY(U,$J,358.3,25934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25934,1,3,0)
 ;;=3^Tardive Akathisia
 ;;^UTILITY(U,$J,358.3,25934,1,4,0)
 ;;=4^G25.71
 ;;^UTILITY(U,$J,358.3,25934,2)
 ;;=^5003799
 ;;^UTILITY(U,$J,358.3,25935,0)
 ;;=G25.79^^69^1070^9
 ;;^UTILITY(U,$J,358.3,25935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25935,1,3,0)
 ;;=3^Medication-Induced Movement Disorder,Other
 ;;^UTILITY(U,$J,358.3,25935,1,4,0)
 ;;=4^G25.79
 ;;^UTILITY(U,$J,358.3,25935,2)
 ;;=^5003800
 ;;^UTILITY(U,$J,358.3,25936,0)
 ;;=T43.205A^^69^1070^4
 ;;^UTILITY(U,$J,358.3,25936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25936,1,3,0)
 ;;=3^Antidepressant Discontinuation Syndrome,Init Encntr
 ;;^UTILITY(U,$J,358.3,25936,1,4,0)
 ;;=4^T43.205A
 ;;^UTILITY(U,$J,358.3,25936,2)
 ;;=^5050540
 ;;^UTILITY(U,$J,358.3,25937,0)
 ;;=T43.205D^^69^1070^5
 ;;^UTILITY(U,$J,358.3,25937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25937,1,3,0)
 ;;=3^Antidepressant Discontinuation Syndrome,Subseq Encntr
 ;;^UTILITY(U,$J,358.3,25937,1,4,0)
 ;;=4^T43.205D
 ;;^UTILITY(U,$J,358.3,25937,2)
 ;;=^5050541
 ;;^UTILITY(U,$J,358.3,25938,0)
 ;;=T43.205S^^69^1070^6
 ;;^UTILITY(U,$J,358.3,25938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25938,1,3,0)
 ;;=3^Antidepressant Discontinuation Syndrome,Sequela
 ;;^UTILITY(U,$J,358.3,25938,1,4,0)
 ;;=4^T43.205S
 ;;^UTILITY(U,$J,358.3,25938,2)
 ;;=^5050542
 ;;^UTILITY(U,$J,358.3,25939,0)
 ;;=G25.71^^69^1070^7
 ;;^UTILITY(U,$J,358.3,25939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25939,1,3,0)
 ;;=3^Medication-Induced Acute Akathisia
 ;;^UTILITY(U,$J,358.3,25939,1,4,0)
 ;;=4^G25.71
 ;;^UTILITY(U,$J,358.3,25939,2)
 ;;=^5003799
 ;;^UTILITY(U,$J,358.3,25940,0)
 ;;=G24.02^^69^1070^8
 ;;^UTILITY(U,$J,358.3,25940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25940,1,3,0)
 ;;=3^Medication-Induced Acute Dystonia
 ;;^UTILITY(U,$J,358.3,25940,1,4,0)
 ;;=4^G24.02
 ;;^UTILITY(U,$J,358.3,25940,2)
 ;;=^5003785
 ;;^UTILITY(U,$J,358.3,25941,0)
 ;;=G21.0^^69^1070^12
 ;;^UTILITY(U,$J,358.3,25941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25941,1,3,0)
 ;;=3^Neuroleptic Malignant Syndrome
 ;;^UTILITY(U,$J,358.3,25941,1,4,0)
 ;;=4^G21.0
 ;;^UTILITY(U,$J,358.3,25941,2)
 ;;=^5003771
 ;;^UTILITY(U,$J,358.3,25942,0)
 ;;=T50.905A^^69^1070^1
 ;;^UTILITY(U,$J,358.3,25942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25942,1,3,0)
 ;;=3^Adverse Effect of Medication,Other,Init Encntr
 ;;^UTILITY(U,$J,358.3,25942,1,4,0)
 ;;=4^T50.905A
 ;;^UTILITY(U,$J,358.3,25942,2)
 ;;=^5052160
 ;;^UTILITY(U,$J,358.3,25943,0)
 ;;=T50.905S^^69^1070^2
 ;;^UTILITY(U,$J,358.3,25943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25943,1,3,0)
 ;;=3^Adverse Effect of Medication,Other,Sequela
 ;;^UTILITY(U,$J,358.3,25943,1,4,0)
 ;;=4^T50.905S
 ;;^UTILITY(U,$J,358.3,25943,2)
 ;;=^5052162
 ;;^UTILITY(U,$J,358.3,25944,0)
 ;;=T50.905D^^69^1070^3
 ;;^UTILITY(U,$J,358.3,25944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25944,1,3,0)
 ;;=3^Adverse Effect of Medication,Other,Subseq Encntr
 ;;^UTILITY(U,$J,358.3,25944,1,4,0)
 ;;=4^T50.905D
 ;;^UTILITY(U,$J,358.3,25944,2)
 ;;=^5052161
 ;;^UTILITY(U,$J,358.3,25945,0)
 ;;=F42.^^69^1071^5
 ;;^UTILITY(U,$J,358.3,25945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25945,1,3,0)
 ;;=3^Obsessive-Compulsive Disorder
 ;;^UTILITY(U,$J,358.3,25945,1,4,0)
 ;;=4^F42.
 ;;^UTILITY(U,$J,358.3,25945,2)
 ;;=^5003568
 ;;^UTILITY(U,$J,358.3,25946,0)
 ;;=F45.22^^69^1071^1
 ;;^UTILITY(U,$J,358.3,25946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25946,1,3,0)
 ;;=3^Body Dysmorphic Disorder
 ;;^UTILITY(U,$J,358.3,25946,1,4,0)
 ;;=4^F45.22
 ;;^UTILITY(U,$J,358.3,25946,2)
 ;;=^5003588
 ;;^UTILITY(U,$J,358.3,25947,0)
 ;;=F63.3^^69^1071^6
 ;;^UTILITY(U,$J,358.3,25947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25947,1,3,0)
 ;;=3^Trichotillomania (Hair-Pulling Disorder)
 ;;^UTILITY(U,$J,358.3,25947,1,4,0)
 ;;=4^F63.3
 ;;^UTILITY(U,$J,358.3,25947,2)
 ;;=^5003643
 ;;^UTILITY(U,$J,358.3,25948,0)
 ;;=L98.1^^69^1071^2
 ;;^UTILITY(U,$J,358.3,25948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25948,1,3,0)
 ;;=3^Excoriation (Skin-Picking) Disorder
 ;;^UTILITY(U,$J,358.3,25948,1,4,0)
 ;;=4^L98.1
 ;;^UTILITY(U,$J,358.3,25948,2)
 ;;=^186781
 ;;^UTILITY(U,$J,358.3,25949,0)
 ;;=F42.^^69^1071^3
 ;;^UTILITY(U,$J,358.3,25949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25949,1,3,0)
 ;;=3^Hoarding Disorder
 ;;^UTILITY(U,$J,358.3,25949,1,4,0)
 ;;=4^F42.
 ;;^UTILITY(U,$J,358.3,25949,2)
 ;;=^5003568
 ;;^UTILITY(U,$J,358.3,25950,0)
 ;;=F06.8^^69^1071^4
 ;;^UTILITY(U,$J,358.3,25950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25950,1,3,0)
 ;;=3^Obsessive-Compulsive & Related Disorder d/t Another Med Condition
 ;;^UTILITY(U,$J,358.3,25950,1,4,0)
 ;;=4^F06.8
 ;;^UTILITY(U,$J,358.3,25950,2)
 ;;=^5003062
 ;;^UTILITY(U,$J,358.3,25951,0)
 ;;=Z91.49^^69^1072^12
 ;;^UTILITY(U,$J,358.3,25951,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25951,1,3,0)
 ;;=3^Personal Hx of Psychological Trauma
 ;;^UTILITY(U,$J,358.3,25951,1,4,0)
 ;;=4^Z91.49
 ;;^UTILITY(U,$J,358.3,25951,2)
 ;;=^5063623
 ;;^UTILITY(U,$J,358.3,25952,0)
 ;;=Z91.5^^69^1072^13
 ;;^UTILITY(U,$J,358.3,25952,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25952,1,3,0)
 ;;=3^Personal Hx of Self-Harm
 ;;^UTILITY(U,$J,358.3,25952,1,4,0)
 ;;=4^Z91.5
 ;;^UTILITY(U,$J,358.3,25952,2)
 ;;=^5063624
 ;;^UTILITY(U,$J,358.3,25953,0)
 ;;=Z91.82^^69^1072^11
 ;;^UTILITY(U,$J,358.3,25953,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25953,1,3,0)
 ;;=3^Personal Hx of Military Deployment
 ;;^UTILITY(U,$J,358.3,25953,1,4,0)
 ;;=4^Z91.82
 ;;^UTILITY(U,$J,358.3,25953,2)
 ;;=^5063626
 ;;^UTILITY(U,$J,358.3,25954,0)
 ;;=Z91.89^^69^1072^18
 ;;^UTILITY(U,$J,358.3,25954,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25954,1,3,0)
 ;;=3^Personal Risk Factors
 ;;^UTILITY(U,$J,358.3,25954,1,4,0)
 ;;=4^Z91.89
 ;;^UTILITY(U,$J,358.3,25954,2)
 ;;=^5063628
 ;;^UTILITY(U,$J,358.3,25955,0)
 ;;=Z72.9^^69^1072^19
 ;;^UTILITY(U,$J,358.3,25955,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25955,1,3,0)
 ;;=3^Problem Related to Lifestyle
 ;;^UTILITY(U,$J,358.3,25955,1,4,0)
 ;;=4^Z72.9
 ;;^UTILITY(U,$J,358.3,25955,2)
 ;;=^5063267
 ;;^UTILITY(U,$J,358.3,25956,0)
 ;;=Z72.811^^69^1072^1
 ;;^UTILITY(U,$J,358.3,25956,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25956,1,3,0)
 ;;=3^Adult Antisocial Behavior
 ;;^UTILITY(U,$J,358.3,25956,1,4,0)
 ;;=4^Z72.811
 ;;^UTILITY(U,$J,358.3,25956,2)
 ;;=^5063263
 ;;^UTILITY(U,$J,358.3,25957,0)
 ;;=Z91.19^^69^1072^5
 ;;^UTILITY(U,$J,358.3,25957,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25957,1,3,0)
 ;;=3^Nonadherence to Medical Treatment
 ;;^UTILITY(U,$J,358.3,25957,1,4,0)
 ;;=4^Z91.19
 ;;^UTILITY(U,$J,358.3,25957,2)
 ;;=^5063618
 ;;^UTILITY(U,$J,358.3,25958,0)
 ;;=E66.9^^69^1072^6
 ;;^UTILITY(U,$J,358.3,25958,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25958,1,3,0)
 ;;=3^Overweight or Obesity
 ;;^UTILITY(U,$J,358.3,25958,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,25958,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,25959,0)
 ;;=Z76.5^^69^1072^3
 ;;^UTILITY(U,$J,358.3,25959,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25959,1,3,0)
 ;;=3^Malingering
 ;;^UTILITY(U,$J,358.3,25959,1,4,0)
 ;;=4^Z76.5
 ;;^UTILITY(U,$J,358.3,25959,2)
 ;;=^5063302
 ;;^UTILITY(U,$J,358.3,25960,0)
 ;;=R41.83^^69^1072^2
 ;;^UTILITY(U,$J,358.3,25960,1,0)
 ;;=^358.31IA^4^2
